Base Metals Investing Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Base Metals Investing Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
Base Metals Investing Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Base Metals Investing Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
Brunswick Exploration Drills 36 Meters at 1.51% and Continues to Extend the Mineralized Footprint of Mirage
